Livermore Lab and BridgeBio Announce Human Trials for HPC-Discovered Cancer Drug
by staff from High-Performance Computing News Analysis | insideHPC on (#6NBA7)
In what Lawrence Livermore National Lab said is "a substantial milestone for supercomputing-aided drug design," LLNLand BridgeBio Oncology Therapeutics today announced clinical trials have begun for ....
The post Livermore Lab and BridgeBio Announce Human Trials for HPC-Discovered Cancer Drug appeared first on High-Performance Computing News Analysis | insideHPC.